What are Integra LifeSciences's total assets?

Integra LifeSciences (IART) holds $3.6B in total assets, down 11.7% year over year.

How much debt does Integra LifeSciences have?

Integra LifeSciences carries $2.0B in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 1.90.

How much cash does Integra LifeSciences have?

Integra LifeSciences holds $236.8M in cash and equivalents.

Can Integra LifeSciences cover its short-term obligations?

Its current ratio is 3.38 — current assets exceed current liabilities.

Where does Integra LifeSciences's balance sheet data come from?

Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Integra LifeSciences IART Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$235.05M-4.6%	$246.38M-10.9%	$276.4M-39.5%	$456.66M-11.1%
Short-term investments	$28.69M+5.5%	$27.19M-16.8%	$32.69M—	$0—
Accounts receivable, net	$278.85M+2.4%	$272.37M+5.0%	$259.33M-1.6%	$263.47M+13.6%
Inventories	$492.74M+14.8%	$429.09M+10.1%	$389.61M+20.0%	$324.58M+2.3%
Work in process	$99.35M+25.1%	$79.42M+7.3%	$74.04M+4.9%	$70.6M+8.1%
Finished goods	$262.61M+17.4%	$223.73M+13.9%	$196.4M+14.1%	$172.09M+5.9%
Prepaid expenses and other current assets	$96.09M+24.8%	$77M+14.3%	$67.36M-42.3%	$116.79M+28.3%
Total current assets	$1.16B+7.2%	$1.08B+2.2%	$1.06B-8.9%	$1.16B+0.7%
Property and equipment, net	$444.34M+9.5%	$405.72M+19.3%	$340.2M+9.3%	$311.3M-0.1%
Accumulated depreciation	$858.07M+17.2%	$732.18M+10.6%	$662M+16.0%	$570.92M+13.9%
Operating lease right-of-use assets	$140.57M-2.4%	$144.04M-7.8%	$156.18M+5.3%	$148.28M+75.4%
Goodwill	$615.16M-43.9%	$1.1B+3.9%	$1.06B+1.6%	$1.04B+2.5%
Intangible assets, net	$1.13B-6.0%	$1.21B+13.1%	$1.07B-5.2%	$1.13B-1.7%
Deferred tax assets	$5.66M-90.7%	$60.83M+72.2%	$35.32M-44.2%	$63.34M+38.3%
Other non-current assets	$71.7M+7.8%	$66.52M+14.3%	$58.19M+1.8%	$57.19M+248%
Total assets	$3.6B-10.8%	$4.04B+6.8%	$3.78B-2.8%	$3.89B+2.8%
Accounts payable	$95.73M+16.0%	$82.5M-10.6%	$92.33M-9.6%	$102.1M+65.1%
Accrued expenses	$74.08M-13.5%	$85.62M+13.5%	$75.46M-4.2%	$78.77M-15.0%
Deferred revenue	$11.46M+9.3%	$10.48M+22.8%	$8.54M+17.7%	$7.25M+37.0%
Current portion of long-term debt	——	——	——	——
Operating lease liabilities, current	$14.02M-3.6%	$14.54M-4.9%	$15.28M+4.5%	$14.62M-1.0%
Contract liabilities	——	——	——	——
Income taxes payable	$3.65M—	$0—	——	——
Total current liabilities	$455.98M-50.6%	$922.13M+200%	$306.98M-4.3%	$320.91M-5.6%
Long-term debt	$1.73B+59.0%	$1.09B+31.8%	$825.56M+12.6%	$733.15M-11.1%
Operating lease liabilities, non-current	$163.06M-2.3%	$166.93M0.0%	$166.85M+6.0%	$157.42M+74.3%
Operating Lease Liabilities (Total)	$177.08M-2.4%	$181.47M-0.4%	$182.13M+5.9%	$172.04M+63.7%
Other non-current liabilities	$204.28M+39.7%	$146.24M-26.9%	$199.94M+44.4%	$138.5M+15.2%
Total liabilities	$2.56B+2.7%	$2.49B+13.6%	$2.19B+5.2%	$2.09B-0.6%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	240M+26,101%	916K+0.8%	909K+0.4%	905K+1.0%
Additional paid-in capital	$1.34B+1.1%	$1.32B+1.6%	$1.3B+2.0%	$1.28B+1.0%
Retained earnings	$423.44M-54.9%	$939.92M-0.7%	$946.86M+7.7%	$879.12M+25.8%
Accumulated other comprehensive income (loss)	-$30.08M-9.1%	-$27.57M-82.5%	-$15.11M-247%	$10.27M+123%
Treasury stock	$689.21M-0.3%	$691.41M+6.8%	$647.26M+78.4%	$362.86M+54.8%
Total stockholders' equity	$1.04B-32.5%	$1.55B-2.7%	$1.59B-12.0%	$1.8B+7.1%
Total liabilities and stockholders' equity	$3.6B-10.8%	$4.04B+6.8%	$3.78B-2.8%	$3.89B+2.8%
Allowance for Doubtful Accounts	$7.23M+4.5%	$6.92M+41.8%	$4.88M+13.4%	$4.3M-9.1%
Allowance for Doubtful Accounts Receivable (Current)	$7.23M+4.5%	$6.92M+41.8%	$4.88M+13.4%	$4.3M-9.1%
Finished goods	$262.61M+17.4%	$223.73M+13.9%	$196.4M+14.1%	$172.09M+5.9%
Other current assets	$28.13M-5.1%	$29.65M-9.2%	$32.64M+5.2%	$31.03M—
Deferred Tax Assets and Other Non-Current Assets	$37.88M-43.1%	$66.52M+14.3%	$58.19M+1.8%	$57.19M+248%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	——	——	——	——
Net Investment in Lease	$140.57M-2.4%	$144.04M-7.8%	$156.18M+5.3%	$148.28M+75.4%
Deferred tax assets	$69.85M+100%	$34.92M-24.2%	$46.08M+0.2%	$45.99M-19.2%
Other intangible assets—net	$1.13B-6.0%	$1.21B+13.1%	$1.07B-5.2%	$1.13B-1.7%
Operating lease right-of-use assets	$140.57M-2.4%	$144.04M-7.8%	$156.18M+5.3%	$148.28M+75.4%
Other non-current assets	$37.88M-43.1%	$66.52M+14.3%	$58.19M+1.8%	$57.19M+248%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$28.69M+5.5%	$27.19M-16.8%	$32.69M—	$0—
Operating Lease Right-of-Use Assets in Other Assets	$140.57M-2.4%	$144.04M-7.8%	$156.18M+5.3%	$148.28M+75.4%
Software and Technology Licenses, Net	$37.88M-43.1%	$66.52M+14.3%	$58.19M+1.8%	$57.19M+248%
Accrued Manufacturing Costs	$74.08M-13.5%	$85.62M+13.5%	$75.46M-4.2%	$78.77M-15.0%
Accrued Progress Collections and Price Adjustments	——	——	——	——
Other Commercial Liabilities	$130.49M+7.0%	$121.91M+20.9%	$100.84M+26.0%	$80.03M-33.6%
Accrued Liabilities, Current	$130.49M+7.0%	$121.91M+20.9%	$100.84M+26.0%	$80.03M-33.6%
Compensation and benefits	$74.08M-13.5%	$85.62M+13.5%	$75.46M-4.2%	$78.77M-15.0%
Current portion of Term Loan	$38.75M+14.3%	$33.91M+133%	$14.53M-61.9%	$38.13M-15.3%
Short-term borrowings under securitization facility	$87.8M—	$0—	——	——
Current portion of borrowings under securitization facility	$87.8M—	——	——	$0—
Finance Lease Liability Payment Due	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Restructuring Reserve	$10.77M+109%	$5.15M+144%	$2.11M—	——
Contract Liabilities, Non-Current	——	——	——	——
Debt Maturity - 2024	——	——	——	——
Debt Maturity - 2027	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	——	——	——
Lease Liability Payments - Due After Year Five	——	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	——	——	——
Deferred revenue, net of current portion	——	——	——	——
Total debt	$1.91B+3.5%	$1.84B+82.8%	$1.01B+11.3%	$905.19M-2.6%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	92.3M+0.7%	91.6M+0.8%	90.9M+0.5%	90.5M+1.0%
Convertible Preferred Stock Authorized Shares	15M0.0%	15M0.0%	15M0.0%	15M0.0%
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Additional paid-in capital	$1.34B+1.1%	$1.32B+1.6%	$1.3B+2.0%	$1.28B+1.0%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$923K+0.8%	$916K+0.8%	$909K+0.4%	$905K+1.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.00—	$0.00—	$0.00—	$0.00—
Components	$130.77M+3.8%	$125.94M+5.7%	$119.17M+45.5%	$81.9M-8.5%
Deferred Revenue Timing Percentage	——	——	——	——
Interest Rate Hedge Reclassification (Next 12 Months)	——	——	——	——
Allowance for doubtful accounts	$7.23M+4.5%	$6.92M+41.8%	$4.88M+13.4%	$4.3M-9.1%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$240M0.0%	$240M0.0%	$240M0.0%	$240M0.0%
Common stock, shares issued (in shares)	$92.29M+0.7%	$91.61M+0.8%	$90.92M+0.5%	$90.48M+1.0%
Contract with Customer, Asset, after Allowance for Credit Loss	$6.84M+11.4%	$6.15M-33.4%	$9.23M-8.8%	$10.12M-11.3%
Contract with Customer, Liability	$23.01M+17.0%	$19.67M+21.0%	$16.25M+0.8%	$16.13M+35.0%
Cost	$1.99B+2.7%	$1.94B+12.1%	$1.73B+1.9%	$1.7B+3.1%
Security facility, weighted average interest rate	4.8%-0.6%	5.4%-1.0%	6.4%+1.4%	5%+3.9%
Deferred compensation plan assets	$7.9M+17.9%	$6.7M+9.8%	$6.1M+29.8%	$4.7M+23.7%
Deferred income taxes	$5.66M-90.7%	$60.83M+72.2%	$35.32M-44.2%	$63.34M+38.3%
Less: Fair value of plan assets at end of period	$71.7M+38.4%	$51.8M+13.3%	$45.7M+19.9%	$38.1M-4.5%
Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill	$1.13B-6.0%	$1.21B+13.1%	$1.07B-5.2%	$1.13B-1.7%
Finance Lease Liability Payments Due	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$858.07M+17.2%	$732.18M+10.6%	$662M+16.0%	$570.92M+13.9%
2028	——	——	——	——
2030	——	——	——	——
2031	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Finite Lived Intangible Assets Amortization Expense After Year Five	——	——	——	——
Interest payments, remainder of fiscal year	——	——	——	——
Interest payments, year one	——	——	——	——
Interest payments, year two	——	——	——	——
Gains expected to be reclassified	——	——	——	——
Inventory, Raw Materials and Purchased Parts, Net of Reserves	$130.77M+3.8%	$125.94M+5.7%	$119.17M+45.5%	$81.9M-8.5%
Lessee Operating Lease Liability Payments Due	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
2028	——	——	——	——
2027	——	——	——	——
Remainder of 2026	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$0—	$0—	$0—	$0—
Preferred Stock, Shares Authorized	$15M0.0%	$15M0.0%	$15M0.0%	$15M0.0%
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Prepaid expenses	$96.09M+24.8%	$77M+14.3%	$67.36M-21.5%	$85.76M—
Receivable for Recovery of Import Duties, Net	——	——	——	——
Restructuring Reserve	$10.77M+109%	$5.15M+144%	$2.11M—	——
Long-term borrowings under securitization facility	$0-100%	$108.1M+21.2%	$89.2M-14.8%	$104.7M-6.9%
Securitization program outstanding borrowings, maximum limit	——	——	——	——
Treasury stock, shares (in shares)	$14.4M-0.3%	$14.45M+13.3%	$12.75M+86.9%	$6.82M+39.3%
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Integra LifeSciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Integra LifeSciences's total assets?: Integra LifeSciences (IART) holds $3.6B in total assets, down 11.7% year over year.
How much debt does Integra LifeSciences have?: Integra LifeSciences carries $2.0B in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 1.90.
How much cash does Integra LifeSciences have?: Integra LifeSciences holds $236.8M in cash and equivalents.
Can Integra LifeSciences cover its short-term obligations?: Its current ratio is 3.38 — current assets exceed current liabilities.
Where does Integra LifeSciences's balance sheet data come from?: Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.